We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 41-60 of 6,430 results
  1. Breast cancer patient-derived microtumors resemble tumor heterogeneity and enable protein-based stratification and functional validation of individualized drug treatment

    Despite tremendous progress in deciphering breast cancer at the genomic level, the pronounced intra- and intertumoral heterogeneity remains a major...

    Nicole Anderle, Felix Schäfer-Ruoff, ... Christian Schmees in Journal of Experimental & Clinical Cancer Research
    Article Open access 18 August 2023
  2. A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma

    Objective

    This study aimed to explore the efficacy and safety of combining epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)...

    Xue Han, Lan Liang, ... ** Zheng in BMC Complementary Medicine and Therapies
    Article Open access 21 November 2023
  3. RETRACTED ARTICLE: Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation

    Background

    Although trastuzumab provides significant clinical benefit for HER2-positive breast cancers, responses are limited by the emergence of...

    Mingli Han, Yuanting Gu, ... Huaying Dong in Molecular Cancer
    Article Open access 05 February 2020
  4. Differential expression profiling of onco and tumor-suppressor genes from major-signaling pathways in Wilms’ tumor

    Purpose

    Wilms’ tumor is the most-frequent malignant-kidney tumor in children under 3–4 years of age and is caused by genetic alterations of oncogenes...

    Dinesh Kumar Sahu, Neetu Singh, ... Devendra Kumar Gupta in Pediatric Surgery International
    Article 15 September 2022
  5. YWHAH, a member of 14-3-3 family proteins, and PSME2, the proteasome activator subunit 2, are key host factors of Japanese encephalitis virus infection

    Background

    Host response to virus infection is key to the effective control and eventual elimination of viruses or infected cells; however, the...

    Chaoyue Liu, Yanhong Yang, ... Mingfei Xu in BMC Medical Genomics
    Article Open access 10 July 2023
  6. Trends in surface plasmon resonance biosensing: materials, methods, and machine learning

    Surface plasmon resonance (SPR) proves to be one of the most effective methods of label-free detection and has been integral for the study of...

    Daniel D. Stuart, Westley Van Zant, ... Quan Cheng in Analytical and Bioanalytical Chemistry
    Article 06 June 2024
  7. Screening and identification of key biomarkers of depression using bioinformatics

    We aimed to identify the molecular biomarkers of MDD disease progression to uncover potential mechanisms of major depressive disorder (MDD). In this...

    **nru Kong, Chuang Wang, ... **anghua Qi in Scientific Reports
    Article Open access 13 March 2023
  8. Overcoming Breast Cancer Resistance to Targeted, Chemo-, and Immuno Therapy: Mechanisms and Strategies to Overcome Resistance and Facilitate Drug Development

    Breast cancer substantially impacts female mortality, and symptoms can differ among individuals. Hence, it is crucial to tailor treatment modalities...
    Adam Hermawan, Sisca Ucche, ... Chris Djerico in
    Chapter 2024
  9. Insulin receptor alternative splicing in breast and prostate cancer

    Cancer etiology represents an intricate, multifactorial orchestration where metabolically associated insulin-like growth factors (IGFs) and insulin...

    **yu Li, Gena Huang in Cancer Cell International
    Article Open access 08 February 2024
  10. ERRα: unraveling its role as a key player in cell migration

    Cell migration is essential throughout the life of multicellular organisms, and largely depends on the spatial and temporal regulation of...

    Jean-Marc Vanacker, Christelle Forcet in Oncogene
    Article 21 December 2023
  11. To be, or not to be: the dilemma of immunotherapy for non-small cell lung cancer harboring various driver mutations

    Introduction

    Lung cancer is one of primary cancer type with high incidence and mortality, non-small cell lung cancer (NSCLC) is the most common type...

    Ruoxue Cai, Hongyu Zhu, ... Ying Fang in Journal of Cancer Research and Clinical Oncology
    Article Open access 01 June 2023
  12. Proteomics-based evaluation of the mechanism underlying vascular injury via DNA interstrand crosslinks, glutathione perturbation, mitogen-activated protein kinase, and Wnt and ErbB signaling pathways induced by crotonaldehyde

    Crotonaldehyde (CRA)—one of the major environmental pollutants from tobacco smoke and industrial pollution—is associated with vascular injury (VI)....

    Ming-Zhang **e, Jun-Li Liu, ... Lu-Yang Jiao in Clinical Proteomics
    Article Open access 24 August 2022
  13. Quantitative systems pharmacology modeling of HER2-positive metastatic breast cancer for translational efficacy evaluation and combination assessment across therapeutic modalities

    HER2-positive (HER2 + ) metastatic breast cancer (mBC) is highly aggressive and a major threat to human health. Despite the significant improvement in...

    Ya-ting Zhou, Jia-hui Chu, ... Chen Zhao in Acta Pharmacologica Sinica
    Article Open access 15 February 2024
  14. Driver and targetable alterations in Chinese patients with small bowel carcinoma

    Purpose

    Small bowel carcinoma (SBA) is a rare gastrointestinal cancer with a poor prognosis. Recent genomic profiling studies revealed that the...

    Jun Li, **aomo Li, ... Wei Deng in Journal of Cancer Research and Clinical Oncology
    Article 21 January 2023
  15. Protein lipidation in health and disease: molecular basis, physiological function and pathological implication

    Posttranslational modifications increase the complexity and functional diversity of proteins in response to complex external stimuli and internal...

    Yuan Yuan, Peiyuan Li, ... **ngxing He in Signal Transduction and Targeted Therapy
    Article Open access 15 March 2024
  16. Endogenous Mechanisms for Cardiomyocyte Regeneration

    Cardiomyocyte proliferationCardiomyocyte proliferation is vital for development of the heartHeart. Mammalian cardiomyocytes (CMs) can vigorously...
    Chandrasekharan C. Kartha in Cardiomyocytes in Health and Disease
    Chapter 2021
  17. Shared mechanisms and crosstalk of COVID-19 and osteoporosis via vitamin D

    Recently accumulated evidence implicates a close association of vitamin D (VitD) insufficiency to the incidence and clinical manifestations of the...

    Fei Liu, Chao Song, ... Zongchao Liu in Scientific Reports
    Article Open access 28 October 2022
  18. Detection of Cancer Biomarker by Advanced Biosensor

    Early diagnosis and prompt therapy are critical for cancer treatment effectiveness. Advanced biosensorsBiosensors are emerging as inexpensive and...
    Stephen Rathinaraj Benjamin, Eli José Miranda Ribeiro Júnior in Targeted Cancer Therapy in Biomedical Engineering
    Chapter 2023
  19. Inhibition of PFKFB3 in HER2-positive gastric cancer improves sensitivity to trastuzumab by inducing tumour vessel normalisation

    Background

    Multiple mechanisms have been proposed that lead to reduced effectiveness of trastuzumab in HER2-positive gastric cancer (GC), yet...

    **ngxing Yao, Zhanke He, ... Jiaolong Shi in British Journal of Cancer
    Article 30 May 2022
  20. Hyaluronan Metabolism and Tumor Progression

    Abstract

    Hereditary and somatic mutations initiating the origin of cancer cells are the key but not the only factor of tumor progression. Activation...

    Article 23 September 2022
Did you find what you were looking for? Share feedback.